U.S. Food and Drug Administration

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizonal rule

FDA Forms Distribution Page for
Center for Drug Evaluation and Research (CDER)

The forms provided by this web site are available in several formats. These formats include:

PDF Adobe Acrobat Portable Document Format (PDF) *
MS WORD Microsoft Word
EXCEL Microsoft Excel
XML Extensible Markup Language
HTML Hypertext Markup Language (HTML)
Fillable Filler Forms

Questions, contact industry support.

(Industry Assistance)

FDA Form # Date Title Format Paper Copy or Contact Info.
356h 10/05 Application to Market a New Drug, Biologic or an Antibiotic Drug for Human Use Fillable P D F CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
1571 04/06 Investigational New Drug Application {Instructions} CBER CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
1572 05/06 Statement of Investigator {Instructions-CDER} PDF

PDF_508

WORD
CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2252 06/08 Transmittal of Annual Report for Drugs and Biologics for Human Use PDF_508 CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2253 06/08 Transmittal of Advertisements and Promotional Labeling for Drugs and Biologics for Human Use PDF_508 DDMAC
301-796-1200
2567 10/02 Transmittal of Labels and Circulars Fillable P D F

WORD
CBER MATT
301-827-2000
2626 07/04 New Drug Application/Biologic Licensing Application (Blue Folder) Archival Not Yet Electronic GPO
2626a 07/04 New Drug Application/Biologic Licensing Application (Red Folder) Chemistry Not Yet Electronic GPO
2626b 07/04 New Drug Application/Biologic Licensing Application (Yellow Folder) Pharmacology Not Yet Electronic GPO
2626c 07/04 New Drug Application/Biologic Licensing Application (Orange Folder) Pharmacokinetic Not Yet Electronic GPO
2626d 07/04 New Drug Application/Biologic Licensing Application (White Folder) Microbiology Not Yet Electronic GPO
2626e 07/04 New Drug Application/Biologic Licensing Application (Tan Folder) Clinical Data Not Yet Electronic GPO
2626f 07/04 New Drug Application/Biologic Licensing Application (Light Green Folder) Statistics Not Yet Electronic GPO
2626h 07/04 New Drug Application/Biologic Licensing Application (Maroon Folder) Field Submission Chemistry Not Yet Electronic GPO
2656 08/07 Registration of Drug Establishment/Labeler Code Assignment {Instructions} THIS FORM MUST BE SUBMITTED IN TRIPLICATE PDF

WORD
DRLS
drls@fda.hhs.gov or 301-210-2840
2657 02/08 Drug Product Listing {Instructions} PDF DRLS
drls@fda.hhs.gov or 301-210-2840
2658 08/07 Registered Establishments Report of Private Label Distributors {Instructions} PDF DRLS
drls@fda.hhs.gov or 301-210-2840
2675 8/90 Investigational New Drug Folder (Red) Not Yet Electronic GPO
2675a 10/86 Investigational New Drug Folder (Green) Not Yet Electronic GPO
2675b 10/86 Investigational New Drug Folder (Orange) Not Yet Electronic GPO
2914 08/08 Radioactive Drug Research Committee (RDRC) Report on Research Use of Radioactive Drugs Membership Summary PDF_508 RDRC
301-796-2050
2915 08/086 Radioactive Drug Research Committee (RDRC) Report on Research Use of Radioactive Drugs Study Summary PDF_508 RDRC
301-796-2050
3316 08/85 Red - DRUG MASTER FILE REVIEW BINDER Not Yet Electronic GPO
3316a 08/85 Blue - DRUG MASTER FILE ARCHIVAL BINDER Not Yet Electronic GPO
3331 04/06 NDA Field Alert Report PDF

WORD
Juliaette Johnson
301-827-8928
3397 01/07 User Fee Cover Sheet HTML Mike Jones
301-443-5151
3437 06/95 CDER Pediatric Use Supplement PDF CDR
301-827-4210
3454 04/06 Certification: Financial Interest and Arrangements of Clinical Investigators PDF

WORD
Leah W. Ripper
301-796-1282
3455 04/06 Disclosure: Financial Interest and Arrangements of Clinical Investigators PDF

WORD
Leah W. Ripper
301-796-1282
3500 02/06 MedWatch: The FDA Safety Information and Adverse Event Reporting Program {Instructions}
PDF-Fillable

HTML
MEDWATCH
1-800-FDA-1088
3500A 02/06 MedWatch: The FDA Safety Information and Adverse Event Reporting Program - Mandatory {Instructions}
PDF-Fillable
MEDWATCH
1-800-FDA-1088
3542 07/07 Patent Information Submitted Upon and After Approval of An NDA or Supplement
PDF
Mary Ann Holovac
240-276-8971
3542a 07/07 Patent Information Submitted With the Filing of An NDA, Amendment, or Supplement PDF

WORD
Mary Ann Holovac
240-276-8971
3613b 06/06 Supplementary Information Certificate of a Pharmaceutical Product PDF

Word
Import/Export Team
CBER 301-827-6201 or CDER 301-827-8940
3664 07/07 My Medicine Record {Instructions} PDF

Word
Cindi Fitzpatrick
301-796-3115

1. To download PDF format: If Acrobat is not available on your PC, go to http://www.adobe.com/prodindex/acrobat/readstep.html.

2. By going to http://www.adobe.com/products/acrobat/access_onlinetools.html provides a set of free tools that allow visually disabled users to read documents in Adobe PDF format. These tools convert PDF documents into either HTML or ASCII text which can then be read by many screen reading programs.

Edition: December 16, 2008

horizonal rule